QUEBEC CITY, Oct. 23, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX:OPS.TO) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced the positive results of the SAFE-TAVI Clinical Study (SavvyWire® Efficacy and Safety in Transcatheter Aortic Valve Implantation Procedures), which were published in JACC: Cardiology Interventions. Results will also be presented at the Transcatheter Cardiovascular Therapeutics Conference (TCT) later this week.
Read more at newswire.caOPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
/Palantir%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock.jpg)
/Robinhood%20app%20on%20phone%20by%20Andrew%20Neel%20via%20Unsplash.jpg)